# Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tilsotolimod-an-investigational-synthetic-toll-like-receptor-9-tlr9-agonist-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Christian Karime,Jing Wang,Gregory Woodhead,Kabir Mody,Charles Hennemeyer,Mitesh J. Borad,Daruka Mahadevan,Sreenivasa R Chandana,Hani M. Babiker |
| Citations | 10 |
| DOI | 10.1080/13543784.2022.2019706 |
| Fields | Immunology and Microbiology |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4200589690 |
| PMID | 34913781 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Christian Karime](https://scholariq.org/researchers/christian-karime/)

## Paper journal

- [Expert Opinion on Investigational Drugs](https://scholariq.org/journals/expert-opinion-on-investigational-drugs/)

## Paper primary topic

- [Immune Response and Inflammation](https://scholariq.org/topics/immune-response-and-inflammation/)

## Paper topics

- [Immune Response and Inflammation](https://scholariq.org/topics/immune-response-and-inflammation/)
- [Immune cells in cancer](https://scholariq.org/topics/immune-cells-in-cancer/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.